Patents
Patents for C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
10/2014
10/21/2014US8865891 Optically-detectable enzyme substrates and their method of use
06/2014
06/04/2014CN103833774A Method of recovering effective components from potassium clavulanate mixed powder
03/2014
03/26/2014EP2710016A1 Regulation of nitric oxide release and biofilm development
03/19/2014CN103649098A Regulation of nitric oxide release and biofilm development
12/2013
12/31/2013US8618285 Triazole derivatives
09/2013
09/18/2013CN103304583A Method for recovering clavulanic acid from clavaminic acid salt crystallization mother liquor
04/2013
04/11/2013US20130090470 Optically-detectable enzyme substrates and their method of use
12/2012
12/26/2012CN102838624A Method for purifying clavulanic acid from fermentation liquor
11/2012
11/27/2012US8318450 Optically-detectable enzyme substrates and their method of use
11/22/2012WO2012155203A1 Regulation of nitric oxide release and biofilm development
11/22/2012CA2835642A1 Regulation of nitric oxide release and biofilm development
02/2012
02/21/2012US8119795 Triazole derivatives II
02/16/2012US20120040380 Optically-detectable enzyme substrates and their method of use
01/2012
01/10/2012CA2408853C Process
08/2011
08/31/2011EP1489061B1 Process for producing cyclic compound
07/2011
07/06/2011EP1165049B2 Agglomerates by crystallisation
02/2011
02/24/2011US20110045082 Agglomerates by crystallisation
02/01/2011CA2364342C Agglomerates by crystallisation
10/2010
10/12/2010US7812014 such as (5R,6Z)-6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, in combination with beta-lactam antibiotics, for the treatment of bacterial infections
08/2010
08/03/2010US7767823 washing, crystallizing
05/2010
05/26/2010CN1649883B Bicyclic 6-alkylidene-penems as lactamases inhibitors
04/2010
04/06/2010US7691842 Tricyclic 6-alkylidene-penems as β-lactamase inhibitors
03/2010
03/30/2010CA2424462C Clavulanic acid pharmaceutical compositions
01/2010
01/28/2010US20100022540 Triazole derivatives ii
05/2009
05/06/2009CN100484943C Novel method for preparing clavulanate
04/2009
04/28/2009CA2425314C Pharmaceutical compositions containing oxapenem-3-carboxylic acids
02/2009
02/19/2009US20090047692 Optically-detectable enzyme substrates and their method of use
12/2008
12/25/2008US20080318921 5R,6Z)-6-(Imidazo[2,1-b][1,3]benzothiazol-2-ylmethylene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; beta -Lactamases hydrolyze beta -lactam antibiotics and as such serve as the primary cause of bacterial resistance
12/18/2008US20080312203 such as (5R,6Z)-6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, in combination with beta-lactam antibiotics, for the treatment of bacterial infections
12/02/2008US7459551 Method for preparing cyclic compounds
11/2008
11/05/2008EP1988093A1 Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
10/2008
10/08/2008CN101279982A Novel method for preparing clavulanate
09/2008
09/10/2008EP1284978B2 Process for the purification of a salt of clavulanic acid
07/2008
07/23/2008EP1326607B1 Pharmaceutical compositions containing oxapenem-3-carboxilic acids
05/2008
05/06/2008CA2237763C Production of a salt of clavulanic acid
04/2008
04/08/2008CA2182504C Process for the preparation of a salt of clavulanic acid
04/01/2008CA2210748C Clavulanic acid extraction process
03/2008
03/18/2008US7344869 Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and Streptomyces hosts capable of improved clavulanic acid production
12/2007
12/27/2007US20070298470 Improving manufacture of clavulanic acid; DNA encoding genes essential for clavam-2-carboxylate (C2C), 2-hydroxymethylclavam (2HMC), or 2-(3-alanyl)clavam (AC) biosynthesis in S. clavuligerus which are not essential for clavulanic acid biosynthesis
11/2007
11/21/2007EP0970087B1 A process for the preparation of a metal salt of clavulanic acid
11/13/2007CA2286369C A process for the preparation of a metal salt of clavulanic acid
07/2007
07/24/2007US7247622 Antibiotic; beta-lactamase inhibitor; therapy for infection
06/2007
06/14/2007CA2783572A1 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
04/2007
04/25/2007CN1312086C Process for producing cyclic compound
10/2006
10/18/2006EP1711504A2 Derivatives of cephalosporin and clavulanic acid for detecting beta-lactamase in a sample
09/2006
09/28/2006US20060217361 Bicyclic 6-alkylidene-penems as beta-lactamase inhibitors
09/26/2006US7112582 penicillins and oxapenicillins with a fused bicyclic N-heteroarymethylene group; 6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; antibiotic resistance is reduced when administered alone or with other B-lactam antibiotics
08/2006
08/08/2006US7087748 Process
08/02/2006CN1267437C Pharmaceutical compositions
06/2006
06/07/2006CN1258535C Process for preparation of metal salt of clavulanic acid
06/06/2006USH2158 Process for the production of clavulanic acid salts
04/2006
04/13/2006US20060079676 washing, crystallizing
04/13/2006US20060079496 Agglomerates by crystallisation
03/2006
03/14/2006CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors
12/2005
12/27/2005US6979735 Agglomerates by crystallization
12/15/2005WO2005071096A3 Derivatives of cephalosporin and clavulanic acid for detecting beta-lacamase in a sample
12/14/2005EP0970198B1 Micro-organisms with increased production of clavulanic acid
12/07/2005EP1326608B1 Stable compositions of oxapenem-3-carboxylic acids by co-lyophilisation with pharmaceutical carriers
11/2005
11/16/2005CN1696301A Process for clavulanic acid production by microbial thallus
10/2005
10/13/2005US20050227309 Optically-detectable enzyme substrates and their method of use
10/12/2005CN1222528C Process for purification of salt of clavulanic acid
09/2005
09/22/2005US20050209450 High yield for industrial production; beta -lactam antibacterial agents; allyl (5R,6S)-6((R)-1-t-butyldimethyl-silyloxyethyl)-7-oxo-3-((R)-2-tetrahydrofuryl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate (3-2)
09/21/2005CN1219512C Pharmaceutical compositions containing oxapenem-3-carboxylic acids
08/2005
08/30/2005US6936458 Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and streptomyces hosts capable of improved clavulanic acid production
08/17/2005CN1656046A Process for producing cyclic compound
08/04/2005WO2005071096A2 Derivatives of cephalosporin and clavulanic acid for detecting beta-lacamase in a sample
08/03/2005CN1649883A Bicyclic 6-alkylidene-penems as lactamases inhibitors
07/2005
07/06/2005CN1209099C Agglomerates by crystallisation
04/2005
04/27/2005CN1198940C Fermentation of clavulanic acid at a controlled level of ammonia
03/2005
03/31/2005US20050070519 Cyclisation process for the preparation of c-2 beta-lactam compounds
03/09/2005CN1192107C 5S clavate alkyl gene separated from rhabdion streptomycete and its application in clavulanic acid production
01/2005
01/26/2005EP1499621A1 Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
12/2004
12/29/2004EP1328528B1 Pharmaceutical compositions comprising clavulanic acid
12/22/2004EP1489061A1 Process for producing cyclic compound
11/2004
11/25/2004DE4307422B4 Verfahren zur Herstellung von Clavulansäuresalzen Process for the preparation of salts of clavulanic acid
11/03/2004EP1319086B1 Process for the preparation of clavulanic acid
09/2004
09/15/2004EP1456393A1 Cyclisation process for the preparation of c-2 beta-lactam compounds
09/08/2004EP0813536B1 Process for the preparation of pharmaceutically acceptable salts of clavulanic acid
08/2004
08/18/2004EP1284978B1 Process for the purification of a salt of clavulanic acid
04/2004
04/22/2004US20040077622 penicillins and oxapenicillins with a fused bicyclic N-heteroarymethylene group; 6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; antibiotic resistance is reduced when administered alone or with other B-lactam antibiotics
04/08/2004US20040067929 Pharmaceutical compositions containing oxapenem-3-carboxylic acids
04/07/2004EP1405913A2 Process for improving the production of 5R clavams
04/01/2004US20040063930 Selective adsorption
03/2004
03/17/2004EP0804441B1 Clavulanic acid extraction process
03/04/2004US20040043981 Pharmaceutical composistions
03/04/2004US20040043980 Bactericides; storage stability
02/2004
02/25/2004EP1165049B1 Agglomerates by crystallisation
02/18/2004EP0874855B1 Production of a salt of clavulanic acid
02/17/2004US6692950 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid
01/2004
01/21/2004CN1469880A Pharmaceutical compositions
01/21/2004CN1469744A Pharmaceutical compositions containing oxapenem-3-carboxylic acids
12/2003
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
11/2003
11/27/2003US20030219867 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid
11/13/2003WO2003093279A1 BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS
11/13/2003CA2483538A1 Bicyclic 6-alkylidene-penems as .szlig.-lactamases inhibitors
10/2003
10/30/2003US20030203886 Process for the production of clavulanic acid salts
10/07/2003CA2208520C Diclavulanate salt with a diamino ether and process of preparation
10/02/2003WO2003080543A1 Process for producing cyclic compound
09/2003
09/04/2003US20030166175 Process for clavulanic acid production
09/03/2003EP0941229B1 Purification of fermented clavulanic acid
1 2 3 4 5 6 7